Internal Medicine, Endocrinology, Diabetes, & Metabolism · Canton, NY
NPI
1295047736
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6119 US Highway 11
Canton, NY, 13617
Phone (315) 261-5810
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,420 services
Medicare patients, 2024
546
Average age 70
Drug cost, 2024
$4.6M
7,780 prescriptions
Company payments, 2025
$203
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul M Tejera was code 99214 (office e&m - established), 764 times for 476 patients. In total Paul M Tejera billed 1,420 services in 9 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 764 | 476 | $67.19 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 290 | 241 | $11.37 | $3,297 |
| 95251 Test - Miscellaneous | Office | 218 | 114 | $25.58 | $5,576 |
| 99204 Office E&M - New | Office | 77 | 77 | $85.50 | $6,583 |
| 99215 Office E&M - Established | Office | 29 | 25 | $90.26 | $2,618 |
| 99213 Office E&M - Established | Office | 26 | 26 | $55.20 | $1,435 |
By year: 2022 $63K for 1,008 services; 2023 $64K for 1,040 services; 2024 $72K for 1,420 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul M Tejera prescribed most often to Medicare patients was Levothyroxine Sodium, with 809 prescriptions and refills. In total Paul M Tejera wrote 7,780 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 809 | 1,731 | 191 | $12K |
| Ozempic Semaglutide | 594 | 1,044 | 143 | $985K |
| Mounjaro Tirzepatide | 367 | 455 | 70 | $472K |
| Jardiance Empagliflozin | 260 | 488 | 60 | $277K |
| Novolog Flexpen Insulin Aspart | 260 | 599 | 97 | $104K |
| Glipizide Generic | 256 | 646 | 77 | $2,447 |
| Metformin Hcl Generic | 252 | 605 | 71 | $1,789 |
| Trulicity Dulaglutide | 247 | 434 | 67 | $409K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 244 | 472 | 66 | $44K |
| Glimepiride Generic | 215 | 527 | 61 | $3,191 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 214 | 528 | 84 | $26K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 210 | 378 | 45 | $125K |
| Tresiba Flextouch U-200 Insulin Degludec | 193 | 491 | 55 | $377K |
| Metformin Hcl Er Metformin Hcl | 152 | 397 | 47 | $2,199 |
| Synthroid Levothyroxine Sodium | 152 | 296 | 30 | $9,018 |
Brand drugs: 4,271 claims; generic drugs: 2,832 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul M Tejera $203 ($203 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $153.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.